Surface phenotype of purified fresh tumor cells
| AntigenPatients: . | CAD . | CAT . | GEN . | GUE . | LAI . | PER . | VOI . | Clone . | Source . |
|---|---|---|---|---|---|---|---|---|---|
| T cells | |||||||||
| CD2 | 7 | 2 | 4 | 37 | 3 | 5 | 1 | RPA-2.10 | PH |
| CD3 | 4 | 8 | 1 | 0 | 3 | 3 | 10 | UCHT-1 | BCI |
| CD4 | 37 | 68 | 89 | 70 | 95 | 88 | 92 | 13B8.2 | BCI |
| CD7 | 73 | 53 | 67 | 0 | 1 | 46 | 0 | M-T701 | PH |
| CD8 | 0 | 2 | 1 | 1 | 1 | 0 | 1 | B9.11 | BCI |
| Monocyte | |||||||||
| CD13 | 2 | 1 | 4 | 1 | 0 | 3 | 0 | WM-47 | Dako |
| CD14 | 2 | 1 | 0 | 0 | 0 | 1 | 0 | RMO52 | BCI |
| CD33 | 1 | 3 | 4 | 0 | 2 | 7 | 0 | WM-54 | Dako |
| CD64 | 2 | 3 | 3 | 0 | 2 | 2 | 1 | 22 | BCI |
| Natural killer cells | |||||||||
| CD16 | 1 | 2 | 4 | 0 | 3 | 3 | 1 | 3G8 | BCI |
| CD56 | 49 | 78 | 15 | 79 | 98 | 96 | 70 | N901 | BCI |
| CD57 | 0 | nd | 0 | 0 | 0 | 0 | 0 | HNK1 | BD |
| CD94 | 5 | nd | 2 | 0 | nd | nd | nd | HP-3D9 | Ancell |
| CD161 | 0 | nd | 1 | 1 | nd | 1 | nd | DX12 | BD |
| Granzyme B* | nd | nd | 95 | 63 | 68 | nd | nd | CLB-GB11 | Pelicluster |
| Perforin*,† | 0 | 0 | 0 | 0 | 0 | 0 | 0 | γG9 | PH |
| B cells | |||||||||
| CD19 | 3 | 4 | 1 | 2 | 0 | 1 | 0 | J4.119 | BCI |
| Cytokine receptor | |||||||||
| CD25 | nd | 32 | 0 | 0 | nd | 6 | 6 | B1.49.9 | BCI |
| CD116 | 1 | 4 | 2 | 4 | 50 | 21 | 33 | M5D12 | PH |
| CD122 | 4 | 1 | 1 | 0 | 1 | 4 | 0 | Mik-β2 | PH |
| CD123 | 88 | 95 | 99 | 98 | 95 | 99 | 97 | 9F5 | PH |
| Dendritic cells | |||||||||
| CD1a | 1 | 1 | 0 | 0 | 0 | 2 | 0 | BL6 | BCI |
| CD1c | 9 | 52 | 5 | 2 | 1 | 17 | nd | L161 | BCI |
| CD11c | 9 | 6 | 1 | 1 | 4 | 7 | 1 | BU15 | BCI |
| CD83 | 1 | 0 | 35 | 6 | 2 | 5 | 0 | HB15a | BCI |
| ILT3 | 85 | 89 | 97 | 98 | 93 | 81 | nd | ZM3.8 | D. Jarrossay, BCI |
| Antigen-presenting cells | |||||||||
| CD40 | 3 | 6 | 32 | 65 | 67 | 6 | 1 | mAb89 | BCI |
| CD80 | 1 | 5 | 0 | 0 | 6 | 3 | 3 | MAB104 | BCI |
| CD86 | 21 | 67 | 12 | 1 | 53 | 13 | 4 | 2331 | PH |
| HLA-ABC | 97 | 100 | 100 | 99 | 100 | 100 | 97 | B9.12.1 | BCI |
| HLA-DR | 83 | 95 | 97 | 78 | 99 | 97 | 100 | B8.12.2 | BCI |
| Miscellaneous | |||||||||
| CD10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ALB1 | BCI |
| CD34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 581 | BCI |
| CD45 RA | 94 | 84 | 99 | 90 | 99 | 98 | 98 | J33 | BCI |
| CD62L | 1 | nd | 64 | 35 | 95 | 33 | nd | DREG56 | BCI |
| CD117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95C3 | BCI |
| CLA | 89 | nd | 0 | 0 | 14 | 2 | nd | HECA-452 | PH |
| AntigenPatients: . | CAD . | CAT . | GEN . | GUE . | LAI . | PER . | VOI . | Clone . | Source . |
|---|---|---|---|---|---|---|---|---|---|
| T cells | |||||||||
| CD2 | 7 | 2 | 4 | 37 | 3 | 5 | 1 | RPA-2.10 | PH |
| CD3 | 4 | 8 | 1 | 0 | 3 | 3 | 10 | UCHT-1 | BCI |
| CD4 | 37 | 68 | 89 | 70 | 95 | 88 | 92 | 13B8.2 | BCI |
| CD7 | 73 | 53 | 67 | 0 | 1 | 46 | 0 | M-T701 | PH |
| CD8 | 0 | 2 | 1 | 1 | 1 | 0 | 1 | B9.11 | BCI |
| Monocyte | |||||||||
| CD13 | 2 | 1 | 4 | 1 | 0 | 3 | 0 | WM-47 | Dako |
| CD14 | 2 | 1 | 0 | 0 | 0 | 1 | 0 | RMO52 | BCI |
| CD33 | 1 | 3 | 4 | 0 | 2 | 7 | 0 | WM-54 | Dako |
| CD64 | 2 | 3 | 3 | 0 | 2 | 2 | 1 | 22 | BCI |
| Natural killer cells | |||||||||
| CD16 | 1 | 2 | 4 | 0 | 3 | 3 | 1 | 3G8 | BCI |
| CD56 | 49 | 78 | 15 | 79 | 98 | 96 | 70 | N901 | BCI |
| CD57 | 0 | nd | 0 | 0 | 0 | 0 | 0 | HNK1 | BD |
| CD94 | 5 | nd | 2 | 0 | nd | nd | nd | HP-3D9 | Ancell |
| CD161 | 0 | nd | 1 | 1 | nd | 1 | nd | DX12 | BD |
| Granzyme B* | nd | nd | 95 | 63 | 68 | nd | nd | CLB-GB11 | Pelicluster |
| Perforin*,† | 0 | 0 | 0 | 0 | 0 | 0 | 0 | γG9 | PH |
| B cells | |||||||||
| CD19 | 3 | 4 | 1 | 2 | 0 | 1 | 0 | J4.119 | BCI |
| Cytokine receptor | |||||||||
| CD25 | nd | 32 | 0 | 0 | nd | 6 | 6 | B1.49.9 | BCI |
| CD116 | 1 | 4 | 2 | 4 | 50 | 21 | 33 | M5D12 | PH |
| CD122 | 4 | 1 | 1 | 0 | 1 | 4 | 0 | Mik-β2 | PH |
| CD123 | 88 | 95 | 99 | 98 | 95 | 99 | 97 | 9F5 | PH |
| Dendritic cells | |||||||||
| CD1a | 1 | 1 | 0 | 0 | 0 | 2 | 0 | BL6 | BCI |
| CD1c | 9 | 52 | 5 | 2 | 1 | 17 | nd | L161 | BCI |
| CD11c | 9 | 6 | 1 | 1 | 4 | 7 | 1 | BU15 | BCI |
| CD83 | 1 | 0 | 35 | 6 | 2 | 5 | 0 | HB15a | BCI |
| ILT3 | 85 | 89 | 97 | 98 | 93 | 81 | nd | ZM3.8 | D. Jarrossay, BCI |
| Antigen-presenting cells | |||||||||
| CD40 | 3 | 6 | 32 | 65 | 67 | 6 | 1 | mAb89 | BCI |
| CD80 | 1 | 5 | 0 | 0 | 6 | 3 | 3 | MAB104 | BCI |
| CD86 | 21 | 67 | 12 | 1 | 53 | 13 | 4 | 2331 | PH |
| HLA-ABC | 97 | 100 | 100 | 99 | 100 | 100 | 97 | B9.12.1 | BCI |
| HLA-DR | 83 | 95 | 97 | 78 | 99 | 97 | 100 | B8.12.2 | BCI |
| Miscellaneous | |||||||||
| CD10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ALB1 | BCI |
| CD34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 581 | BCI |
| CD45 RA | 94 | 84 | 99 | 90 | 99 | 98 | 98 | J33 | BCI |
| CD62L | 1 | nd | 64 | 35 | 95 | 33 | nd | DREG56 | BCI |
| CD117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95C3 | BCI |
| CLA | 89 | nd | 0 | 0 | 14 | 2 | nd | HECA-452 | PH |